Engimmune Therapeutics

About:

Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.

Website: https://www.engimmune.com

Top Investors: Novo Holdings, Pureos Bioventures, Kinled Holding, BaseLaunch

Description:

Engimmune Therapeutics is a platform and product development company using cutting-edge technologies in the life sciences engineering highly potent and specific therapies based on T cell receptors (TCR) targeting solid tumors.